Pfizer reposted this
Today I have the privilege of announcing that Dr. Chris Boshoff, MD, PhD, FMedSci has been appointed to lead our pipeline of potential new medicines and vaccines—work that is at the very heart of Pfizer's ability to change patients' lives. Effective January 1, 2025, Chris will become Pfizer’s new Chief Scientific Officer and President, Research & Development, overseeing all functions of Pfizer’s R&D across all therapeutic areas. In his current role as our Chief Oncology Officer, Chris has shaped Pfizer Oncology into one of our most productive divisions. In his 11 years at Pfizer, he has delivered an impressive 24 approved innovative medicines and biosimilars in more than 30 indications, and I am confident that he will accomplish great things across our entire portfolio. He is an extraordinary scientist and leader with a passion for helping patients. Throughout our comprehensive selection process, Chris stood out as a proven leader with a compelling vision for the future of Pfizer R&D. Chris will succeed Dr. Mikael Dolsten, who is retiring at the end of the year. I want to thank Mikael for his dedication and all that he has contributed during his long tenure at Pfizer. I’m also thrilled to announce Dr. Roger Dansey will serve as Interim Chief Oncology Officer and to welcome Dr. Johanna Bendell to Pfizer as our new Chief Development Officer, Oncology. Roger will work with Chris in selecting a permanent candidate for the role. I look forward to working with these talented leaders and their teams to continue advancing scientific breakthroughs that help patients everywhere. https://lnkd.in/eXT2ekYa
Where can an average person find data that shows how many cancers have been cured or slowed due to a pharmaceutical product? How big is the role immunotherapy is playing now in long term oncology care?
Congratulations! Let’s get that Pfizer stock price up!! It’s been an underperforming stock for years!!! Pfizer was a leader in breakthrough therapy’s and the markets responded !!!
"Congratulations to Dr. Chris Boshoff on his well-deserved appointment as Pfizer's new Chief Scientific Officer and President, Research & Development! 🌟 With his remarkable track record in Oncology and his visionary leadership, I have no doubt he will continue to drive groundbreaking innovations that will positively impact patients' lives. Excited to see the next chapter of scientific advancements under his guidance. Also, a big thank you to Dr. Mikael Dolsten for his invaluable contributions to Pfizer’s success! Wishing everyone continued success in advancing the future of healthcare. #Leadership #Innovation #Pharma"
Félicitations tout d'abord puis j'annonce que je possède la découverte d'une nouvelle thérapie efficace contre le cancer couronnée par un médicament breveté je cherche à vendre la licence d'exploitation à un grand laboratoire comme Pfizer..
Wishing everyone at Pfizer continued success in transforming patient care!
I look forward to Pfizer, helping people get healthy again. And a little more honesty.
Congratulations to Dr. Chris Boshoff on this exciting new role! With such a strong track record in oncology, it will be interesting to see how his leadership will shape the future of R&D. The commitment to advancing patient care is truly inspiring. Best wishes to both Chris and Mikael as they embark on these new chapters!
Congratulations to Dr. Chris Boshoff on this new role and to Dr. Johanna Bendell on joining Pfizer! It's exciting to see the leadership shaping the future of R&D and oncology. Wishing Dr. Mikael Dolsten the best in his retirement. Looking forward to witnessing the advancements this team will bring to patients globally.
Pfizer CONGRATULATIONS, YOUR COMPANY IS SETTING THE BENCHMARK HOW TO HELP PEOPLE BUILD THE BEST CORPORATE CAREER.
"Quod scripsi, scripsi." -Pontius Pilate
3moDoes subjecting a functional body to fake/synthetic drugs that don't replicate any biological functions create new illnesses as a side effect of fake/synthetic drugs working against a functional body? Do functional/organic compound's that work/replicate endogenous biological functions not sell because, by law, functional/natural/epigenetic compounds can't be branded into fake/synthetic drug formulations that don't work/don't serve any functions? How does big pharma get away with branding a functional compound, Desoxyn, into synthetic adrenergic amphetamine drug formulations that don't work in the brain and causes physical stimulation as a side effect of amphetamine stimulating the peripheral nervous system/adrenaline instead of the central nervous system/dopamine?